ArticleThe Journal of antimicrobial chemotherapy2016

Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors.

Bluma G Brenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.